このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Therma Bright マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Rob Fia

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	8.1yrs
CEOの所有権	7.2%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	6.4yrs

経営陣の近況

Recent updates

Is Therma Bright (CVE:THRM) In A Good Position To Invest In Growth?

Nov 02

We Think Therma Bright (CVE:THRM) Can Afford To Drive Business Growth

Jul 04

CEO報酬分析

Therma Bright の収益と比較して、Rob Fia の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Jan 31 2024	n/a	n/a	-CA$3m
Oct 31 2023	n/a	n/a	-CA$3m
Jul 31 2023	n/a	n/a	-CA$4m
Apr 30 2023	n/a	n/a	-CA$3m
Jan 31 2023	n/a	n/a	-CA$3m
Oct 31 2022	n/a	n/a	-CA$4m
Jul 31 2022	CA$733k	CA$125k	-CA$6m
Apr 30 2022	n/a	n/a	-CA$6m
Jan 31 2022	n/a	n/a	-CA$7m
Oct 31 2021	n/a	n/a	-CA$8m
Jul 31 2021	CA$600k	CA$125k	-CA$9m
Apr 30 2021	n/a	n/a	-CA$8m
Jan 31 2021	n/a	n/a	-CA$6m
Oct 31 2020	n/a	n/a	-CA$4m
Jul 31 2020	CA$53k	CA$53k	-CA$627k
Apr 30 2020	n/a	n/a	CA$158k
Jan 31 2020	n/a	n/a	CA$10k
Oct 31 2019	n/a	n/a	-CA$260k
Jul 31 2019	CA$15k	CA$15k	-CA$422k
Apr 30 2019	n/a	n/a	-CA$1m
Jan 31 2019	n/a	n/a	-CA$1m
Oct 31 2018	n/a	n/a	-CA$1m
Jul 31 2018	CA$30k	CA$30k	-CA$1m
Apr 30 2018	n/a	n/a	-CA$1m
Jan 31 2018	n/a	n/a	-CA$1m
Oct 31 2017	n/a	n/a	-CA$1m
Jul 31 2017	CA$100k	CA$100k	-CA$966k

報酬と市場: Robの総報酬がCanadian市場の同規模の企業と比較して妥当かどうかを判断するにはデータが不十分です。

報酬と収益: Robの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Rob Fia (54 yo)

8.1yrs

在職期間

CA$732,500

報酬

Mr. Roberto Fia, also known as Rob, CFA, serves as the Chairman and President of Therma Bright Inc. (formerly known as The Jenex Corporation) and has been its Chief Executive Officer since May 18, 2016. Mr...

取締役

名称	ポジション	在職期間	報酬	所有権
Roberto Fia	Chairman	14.8yrs	CA$732.50k	7.16% CA$ 718.0k
Bruno Maruzzo	Member of Advisory Board	6.1yrs	データなし	データなし
Gilbert Sharpe	Member of Advisory Board	6.3yrs	データなし	データなし
Andrew Peterson	Independent Director	6.4yrs	データなし	0.29% CA$ 28.7k
Sungbum Huh	Independent Director	6yrs	データなし	データなし
Joseph Heng	Independent Director	8.1yrs	データなし	データなし
Stephen McNeill	Member of Advisory Board	6.4yrs	データなし	データなし
Leonidas Notidis	Member of Advisory Board	6.4yrs	データなし	データなし
Michael Bosman	Member of Advisory Board	6.4yrs	データなし	データなし
Steven Bennett	Member of Advisory Board	6.1yrs	データなし	データなし
Too Min	Member of Advisory Board	5.8yrs	データなし	データなし

6.4yrs

平均在職期間

72yo

平均年齢

経験豊富なボード: THRMの取締役会は経験豊富であると考えられます ( 6.4年の平均在任期間)。

Therma Bright マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Insufficient new directors

Therma Bright Inc., Annual General Meeting, Dec 18, 2023

Insufficient new directors

Therma Bright Inc., Annual General Meeting, Jun 17, 2022

Independent Director recently sold CA$255k worth of stock

Therma Bright Inc. Appoints Ian Levine to the Advisory Board

Recent updates

New major risk - Shareholder dilution

Therma Bright Inc. announced that it expects to receive CAD 1 million in funding

Second quarter 2024 earnings released: EPS: CA$0 (vs CA$0.003 loss in 2Q 2023)

Insufficient new directors

Therma Bright Inc., Annual General Meeting, Dec 18, 2023

New major risk - Share price stability

Third quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.005 loss in 3Q 2022)

Therma Bright Inc. and Inretio Inc. Announces Successful Completion of Good Laboratory Practice Study for Its Breakthrough Preva™? Mechanical Thrombectomy Device

Second quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.005 loss in 2Q 2022)

Full year 2022 earnings released: CA$0.026 loss per share (vs CA$0.043 loss in FY 2021)

Insufficient new directors

Is Therma Bright (CVE:THRM) In A Good Position To Invest In Growth?

Therma Bright Inc. Provides Update on FDA EUA Review Process

Therma Bright Inc. Provides Updates on Applications for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test

We Think Therma Bright (CVE:THRM) Can Afford To Drive Business Growth

Third quarter 2022 earnings released: CA$0.005 loss per share (vs CA$0.011 loss in 3Q 2021)

Therma Bright Submits Health Canada Application for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test for Point-of-Care (POC)

Therma Bright Inc. Provides Update on FDA EUA Application Process for Acuvid(TM) Covid-19 Rapid Antigen Saliva Test

Therma Bright to Submit Application to Health Canada for Approval of its AcuVid COVID-19 Rapid Antigen Saliva Test

Therma Bright Inc., Annual General Meeting, Jun 17, 2022

Second quarter 2022 earnings released: CA$0.005 loss per share (vs CA$0.008 loss in 2Q 2021)

Therma Bright Inc. announced that it has received CAD 6 million in funding

Therma Bright Inc. announced that it expects to receive CAD 6 million in funding

Therma Bright's AcuVid(TM) U.S. Clinical Performance Study Successfully Exceeds U.S. Food & Drug Administration's Emergency Use Authorization Requirements

Therma Bright Inc. Completes U.S. Clinical Performance Study Subject Recruitment

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Therma Bright Inc. to Test AcuVidTM on the Highly Contagious COVID-19 Delta Variant; Completes Brazilian Clinical Study for Final FDA EUA Submission

Therma Bright Inc. Provides an Update on the Exceptional Performance of Its AcuVidTM COVID-19 Rapid Antigen Saliva Test's Brazilian Clinical Study

Therma Bright Inc. Provides Update on its Brazilian Clinical Study of its Innovative 15- Minute COVID-19 Antigen Saliva Test

Therma Bright Inc. Initiates Clinical Performance Study in Brazil for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

Therma Bright Inc. Submits Application to Research Ethics Board for Approval of Clinical Trials for AcuVid (TM) Covid-19 Rapid Saliva- Based Antigen Test

Therma Bright Enters into Clinical Trial Agreement for Its Acuvid(Tm) Covid-19 Rapid Saliva-Based Antigen Test

Independent Director recently sold CA$255k worth of stock

Therma Bright Inc. Reports Improved Accuracy for Covid-19 Rapid Saliva Antigen Test, CoviSafe, and Prepares for Prospective Studies

Therma Bright Inc. Appoints Ian Levine to the Advisory Board

New 90-day high: CA$0.35

First quarter 2021 earnings released: CA$0.018 loss per share

Chairman exercised options to buy CA$248k worth of stock.

New 90-day high: CA$0.28

Full year 2020 earnings released: CA$0.004 loss per share

Therma Bright Inc. (TSXV:THRM) completed the acquisition of assets of Saringer Life Science Technologies Inc. for CAD 0.43 million.

Therma Bright Inc. announced that it has received CAD 1.25 million in funding

New 90-day high - CA$0.30

Therma Bright Inc. announced that it expects to receive CAD 1 million in funding

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

取締役

平均在職期間

平均年齢

マネジメント基準チェック /14